TCW Group’s Impax Laboratories, Inc. IPXL Stock Holding History

TCW Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,342,835	Closed	-$45.6M	–	379
2018 Q1	$45.6M	Buy	2,342,835 +354,885	+18%	+$6.96M	0.37%	80
2017 Q4	$33.1M	Buy	1,987,950 +1,938,307	+3,904%	+$35.5M	0.27%	84
2017 Q3	$1.01M	Buy	49,643 +12,063	+32%	+$231K	0.01%	283
2017 Q2	$605K	Buy	+37,580	New	+$555K	0.01%	333

TCW Group's IPXL Position: Q2 2018 in Review

TCW Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 2,342,835 shares — an estimated $45.6M sold.

TCW Group first reported a position in IPXL in Q2 2017 and held it in 4 quarters. The position peaked at $45.6M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

TCW Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
TCW Group sold 2,342,835 Impax Laboratories, Inc. shares in Q2 2018, an estimated $45.6M.
TCW Group first reported a position in Impax Laboratories, Inc. in Q2 2017 and held it in 4 quarters.
TCW Group's Impax Laboratories, Inc. position peaked at $45.6M in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on TCW Group's 13F filing for Q2 2018, filed 2 Aug 2018.